Skip to main content
. 2008 Jan 14;1(2):85–88. doi: 10.1093/ndtplus/sfm048

Fig. 1.

Fig. 1

Clinical course of proteinuria after third relapse of FSGS and response to plasma exchange (PE) and rituximab.